• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应用心血管磁共振测量血液透析后心脏结构和组织特征参数的急性变化。

Acute changes in cardiac structural and tissue characterisation parameters following haemodialysis measured using cardiovascular magnetic resonance.

机构信息

Institute of Cardiovascular Science, University College London, London, UK.

Royal Free Hospital, London, UK.

出版信息

Sci Rep. 2019 Feb 4;9(1):1388. doi: 10.1038/s41598-018-37845-4.

DOI:10.1038/s41598-018-37845-4
PMID:30718606
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6362126/
Abstract

In patients with chronic kidney disease (CKD), reverse left ventricular (LV) remodelling, including reduction in LV mass, can be observed following long-term haemodialysis (HD) and has been attributed to regression of LV hypertrophy. However, LV mass can vary in response to changes in myocyte volume, edema, or fibrosis. The aims of this study were to investigate the acute changes in structural (myocardial mass and biventricular volumes) and tissue characterization parameters (native T1 and T2) following HD using cardiovascular magnetic resonance (CMR). Twenty-five stable HD patients underwent non-contrast CMR including volumetric assessment and native T1 and T2 mapping immediately pre- and post-HD. The mean time between the first and second scan was 9.1 ± 1.1 hours and mean time from completion of dialysis to the second scan was 3.5 ± 1.3 hours. Post-HD, there was reduction in LV mass (pre-dialysis 98.9 ± 36.9 g/m vs post-dialysis 93.3 ± 35.8 g/m, p = 0.003), which correlated with change in body weight (r = 0.717, p < 0.001). Both native T1 and T2 reduced significantly following HD (Native T1: pre-dialysis 1085 ± 43 ms, post-dialysis 1072 ± 43 ms; T2: pre-dialysis 53.3 ± 3.0 ms, post-dialysis 51.8 ± 3.1 ms, both p < 0.05). These changes presumably reflect acute reduction in myocardial water content rather than regression of LV hypertrophy. CMR with multiparametric mapping is a promising tool to assess the cardiac changes associated with HD.

摘要

在慢性肾脏病(CKD)患者中,长期血液透析(HD)后可观察到左心室(LV)反向重构,包括 LV 质量减轻,这归因于 LV 肥大的消退。然而,LV 质量会因心肌细胞体积、水肿或纤维化的变化而变化。本研究旨在使用心血管磁共振(CMR)研究 HD 后结构(心肌质量和双心室容积)和组织特征参数(原生 T1 和 T2)的急性变化。25 例稳定的 HD 患者在 HD 前后立即进行非对比 CMR 检查,包括容积评估和原生 T1 和 T2 绘图。第一次和第二次扫描之间的平均时间为 9.1±1.1 小时,从透析完成到第二次扫描的平均时间为 3.5±1.3 小时。HD 后,LV 质量降低(透析前 98.9±36.9g/m 对透析后 93.3±35.8g/m,p=0.003),与体重变化相关(r=0.717,p<0.001)。HD 后原生 T1 和 T2 均显著降低(原生 T1:透析前 1085±43ms,透析后 1072±43ms;T2:透析前 53.3±3.0ms,透析后 51.8±3.1ms,均 p<0.05)。这些变化可能反映了心肌含水量的急性减少,而不是 LV 肥大的消退。CMR 与多参数绘图相结合是评估与 HD 相关的心脏变化的有前途的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ef/6362126/b72fba760d0c/41598_2018_37845_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ef/6362126/84b1c62718f1/41598_2018_37845_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ef/6362126/92985c18dee6/41598_2018_37845_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ef/6362126/d4d66748088a/41598_2018_37845_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ef/6362126/d7f6d2aa4260/41598_2018_37845_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ef/6362126/30935de7981e/41598_2018_37845_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ef/6362126/b72fba760d0c/41598_2018_37845_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ef/6362126/84b1c62718f1/41598_2018_37845_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ef/6362126/92985c18dee6/41598_2018_37845_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ef/6362126/d4d66748088a/41598_2018_37845_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ef/6362126/d7f6d2aa4260/41598_2018_37845_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ef/6362126/30935de7981e/41598_2018_37845_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83ef/6362126/b72fba760d0c/41598_2018_37845_Fig6_HTML.jpg

相似文献

1
Acute changes in cardiac structural and tissue characterisation parameters following haemodialysis measured using cardiovascular magnetic resonance.应用心血管磁共振测量血液透析后心脏结构和组织特征参数的急性变化。
Sci Rep. 2019 Feb 4;9(1):1388. doi: 10.1038/s41598-018-37845-4.
2
Myocardial changes on 3T cardiovascular magnetic resonance imaging in response to haemodialysis with fluid removal.3T 心血管磁共振成像中血液透析去除液体后心肌变化。
J Cardiovasc Magn Reson. 2021 Nov 11;23(1):125. doi: 10.1186/s12968-021-00822-4.
3
Identification of cardiovascular abnormalities by multiparametric magnetic resonance imaging in end-stage renal disease patients with preserved left ventricular ejection fraction.多参数磁共振成像在左心室射血分数保留的终末期肾病患者中心血管异常的识别。
Eur Radiol. 2021 Sep;31(9):7098-7109. doi: 10.1007/s00330-021-07752-w. Epub 2021 Feb 24.
4
Myocardial changes in incident haemodialysis patients over 6-months: an observational cardiac magnetic resonance imaging study.新发血液透析患者6个月内心肌变化:一项心脏磁共振成像观察性研究
Sci Rep. 2017 Oct 25;7(1):13976. doi: 10.1038/s41598-017-14481-y.
5
Native T1 mapping: inter-study, inter-observer and inter-center reproducibility in hemodialysis patients.原生T1映射:血液透析患者研究间、观察者间及中心间的可重复性
J Cardiovasc Magn Reson. 2017 Feb 27;19(1):21. doi: 10.1186/s12968-017-0337-7.
6
Myocardial Injury in Peritoneal Dialysis Patients Assessed by Multiparametric MRI: Relationship With Left Ventricular Phenotypes.多参数 MRI 评估腹膜透析患者的心肌损伤:与左心室表型的关系。
J Magn Reson Imaging. 2024 Nov;60(5):1934-1947. doi: 10.1002/jmri.29261. Epub 2024 Feb 4.
7
Contrast-enhanced cardiac MRI is superior to non-contrast mapping to predict left ventricular remodeling at 6 months after acute myocardial infarction.对比增强心脏 MRI 优于非对比映射,可预测急性心肌梗死后 6 个月的左心室重构。
Eur Radiol. 2024 Mar;34(3):1863-1874. doi: 10.1007/s00330-023-10100-9. Epub 2023 Sep 4.
8
Associations of B-type natriuretic peptide (BNP) and dialysis vintage with CMRI-derived cardiac indices in stable hemodialysis patients with a preserved left ventricular ejection fraction.在左心室射血分数保留的稳定血液透析患者中,B型利钠肽(BNP)和透析龄与心脏磁共振成像(CMRI)得出的心脏指数之间的关联。
Int J Cardiovasc Imaging. 2020 Nov;36(11):2265-2278. doi: 10.1007/s10554-020-01942-1. Epub 2020 Jul 19.
9
Left Ventricular Myocardial Fibrosis, Atrophy, and Impaired Contractility in Patients With Pulmonary Arterial Hypertension and a Preserved Left Ventricular Function: A Cardiac Magnetic Resonance Study.肺动脉高压且左心室功能保留患者的左心室心肌纤维化、萎缩及收缩功能受损:一项心脏磁共振研究
J Thorac Imaging. 2017 Jan;32(1):36-42. doi: 10.1097/RTI.0000000000000248.
10
Cardiac Involvement in Patients Recovered From COVID-2019 Identified Using Magnetic Resonance Imaging.利用磁共振成像技术识别 COVID-19 康复患者的心脏受累情况。
JACC Cardiovasc Imaging. 2020 Nov;13(11):2330-2339. doi: 10.1016/j.jcmg.2020.05.004. Epub 2020 May 12.

引用本文的文献

1
Effects of acute hydration changes on cardiovascular magnetic resonance native T1 and T2 mapping.急性水化变化对心血管磁共振原生T1和T2成像的影响。
Int J Cardiovasc Imaging. 2025 Feb;41(2):199-209. doi: 10.1007/s10554-024-03291-9. Epub 2024 Dec 26.
2
Myocardial involvement in end-stage renal disease patients with anemia as assessed by cardiovascular magnetic resonance native T1 mapping: An observational study.心血管磁共振原生 T1 映射评估贫血终末期肾病患者的心肌受累:一项观察性研究。
Medicine (Baltimore). 2024 Nov 15;103(46):e39724. doi: 10.1097/MD.0000000000039724.
3
Myocardial hypertrophy: the differentiation of uremic, hypertensive, and hypertrophic cardiomyopathies by cardiac MRI.

本文引用的文献

1
Age and sex corrected normal reference values of T1, T2 T2* and ECV in healthy subjects at 3T CMR.3T CMR 健康受试者 T1、T2、T2* 和 ECV 的年龄和性别校正正常参考值。
J Cardiovasc Magn Reson. 2017 Sep 21;19(1):72. doi: 10.1186/s12968-017-0371-5.
2
Native T1 mapping: inter-study, inter-observer and inter-center reproducibility in hemodialysis patients.原生T1映射:血液透析患者研究间、观察者间及中心间的可重复性
J Cardiovasc Magn Reson. 2017 Feb 27;19(1):21. doi: 10.1186/s12968-017-0337-7.
3
Myocardial T-mapping at 3T using saturation-recovery: reference values, precision and comparison with MOLLI.
心肌肥厚:通过心脏磁共振成像鉴别尿毒症性、高血压性和肥厚性心肌病
Insights Imaging. 2024 Aug 1;15(1):190. doi: 10.1186/s13244-024-01770-0.
4
Cardiac Magnetic Resonance Imaging Findings in Patients With Chronic Kidney Disease and End-Stage Kidney Disease: A Systematic Review and Meta-Analysis.慢性肾脏病和终末期肾病患者的心脏磁共振成像结果:一项系统评价和荟萃分析
Cureus. 2024 Jan 4;16(1):e51672. doi: 10.7759/cureus.51672. eCollection 2024 Jan.
5
Native T2 Predicts Myocardial Inflammation Irrespective of a Patient's Volume Status.无论患者的容量状态如何,固有T2均可预测心肌炎症。
Diagnostics (Basel). 2023 Jun 30;13(13):2240. doi: 10.3390/diagnostics13132240.
6
Randomized trial comparing standard versus thermocontrolled haemodialysis using intradialytic cardiac, brain and renal magnetic resonance imaging.随机对照试验比较标准与热控血液透析对心脏、大脑和肾脏的磁共振成像。
Nephrol Dial Transplant. 2024 Jan 31;39(2):233-241. doi: 10.1093/ndt/gfad150.
7
Knowledge landscapes and emerging trends of cardiorenal syndrome type 4: a bibliometrics and visual analysis from 2004 to 2022.心肾综合征 4 型的知识图谱和新兴趋势:2004 年至 2022 年的文献计量学和可视化分析。
Int Urol Nephrol. 2024 Jan;56(1):155-166. doi: 10.1007/s11255-023-03680-4. Epub 2023 Jul 9.
8
Cardiac Imaging Biomarkers in Chronic Kidney Disease.慢性肾脏病的心脏影像标志物。
Biomolecules. 2023 Apr 29;13(5):773. doi: 10.3390/biom13050773.
9
Why is Intradialytic Hypotension the Commonest Complication of Outpatient Dialysis Treatments?为何透析中低血压是门诊透析治疗最常见的并发症?
Kidney Int Rep. 2022 Nov 10;8(3):405-418. doi: 10.1016/j.ekir.2022.10.031. eCollection 2023 Mar.
10
Native T1 is predictive of cardiovascular death/heart failure events and all-cause mortality irrespective of the patient's volume status.无论患者的容量状态如何,固有T1可预测心血管死亡/心力衰竭事件及全因死亡率。
Front Cardiovasc Med. 2023 Feb 14;10:1091334. doi: 10.3389/fcvm.2023.1091334. eCollection 2023.
使用饱和恢复法在3T下进行心肌T值映射:参考值、精密度及与MOLLI的比较
J Cardiovasc Magn Reson. 2016 Nov 18;18(1):84. doi: 10.1186/s12968-016-0302-x.
4
Defining myocardial tissue abnormalities in end-stage renal failure with cardiac magnetic resonance imaging using native T1 mapping.使用原生T1映射的心脏磁共振成像定义终末期肾衰竭中的心肌组织异常。
Kidney Int. 2016 Oct;90(4):845-52. doi: 10.1016/j.kint.2016.06.014. Epub 2016 Aug 5.
5
The Validity of Left Ventricular Mass as a Surrogate End Point for All-Cause and Cardiovascular Mortality Outcomes in People With CKD: A Systematic Review and Meta-analysis.左心室质量作为 CKD 患者全因和心血管死亡率替代终点的有效性:系统评价和荟萃分析。
Am J Kidney Dis. 2016 Oct;68(4):554-563. doi: 10.1053/j.ajkd.2016.03.418. Epub 2016 Apr 30.
6
Comprehensive Cardiac Magnetic Resonance Imaging in Patients With Suspected Myocarditis: The MyoRacer-Trial.疑似心肌炎患者的全面心脏磁共振成像:MyoRacer 试验。
J Am Coll Cardiol. 2016 Apr 19;67(15):1800-1811. doi: 10.1016/j.jacc.2016.02.013.
7
T1 mapping and T2 mapping at 3T for quantifying the area-at-risk in reperfused STEMI patients.在3T场强下进行T1映射和T2映射以量化再灌注ST段抬高型心肌梗死患者的危险区域。
J Cardiovasc Magn Reson. 2015 Aug 12;17(1):73. doi: 10.1186/s12968-015-0173-6.
8
Reproducibility of native myocardial T1 mapping in the assessment of Fabry disease and its role in early detection of cardiac involvement by cardiovascular magnetic resonance.天然心肌T1映射在法布里病评估中的可重复性及其在心血管磁共振早期检测心脏受累中的作用。
J Cardiovasc Magn Reson. 2014 Dec 5;16(1):99. doi: 10.1186/s12968-014-0099-4.
9
T1 mapping and survival in systemic light-chain amyloidosis.T1映射与系统性轻链淀粉样变性的生存情况
Eur Heart J. 2015 Jan 21;36(4):244-51. doi: 10.1093/eurheartj/ehu444. Epub 2014 Nov 16.
10
T1 Mapping for Characterization of Intracellular and Extracellular Myocardial Diseases in Heart Failure.用于心力衰竭中细胞内和细胞外心肌疾病特征描述的T1映射
Curr Cardiovasc Imaging Rep. 2014;7(9):9287. doi: 10.1007/s12410-014-9287-8.